PURE Bioscience, Inc.
PURE
$0.05
$0.00-0.42%
OTC PK
| 10/31/2025 | 07/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -7.33% | 55.60% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -7.33% | 55.60% | |||
| Cost of Revenue | -12.84% | 42.31% | |||
| Gross Profit | -3.85% | 65.37% | |||
| SG&A Expenses | 1.64% | -5.80% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -1.18% | 2.33% | |||
| Operating Income | -12.80% | 42.47% | |||
| Income Before Tax | -39.76% | 42.76% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -39.76% | 42.76% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -39.76% | 42.76% | |||
| EBIT | -12.80% | 42.47% | |||
| EBITDA | -12.50% | 42.37% | |||
| EPS Basic | -36.67% | 42.31% | |||
| Normalized Basic EPS | -36.84% | 40.63% | |||
| EPS Diluted | -36.67% | 42.31% | |||
| Normalized Diluted EPS | -36.84% | 40.63% | |||
| Average Basic Shares Outstanding | 0.00% | 0.02% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.02% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||